Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Exelixis Inc (NASDAQ: EXEL) closed at $45.17 in the last session, up 2.50% from day before closing price of $44.07. In other words, the price has increased by $2.50 from its previous closing price. On the day, 2.0 million shares were traded. EXEL stock price reached its highest trading level at $45.305 during the session, while it also had its lowest trading level at $43.885.
Ratios:
We take a closer look at EXEL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.01. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on July 08, 2025, Downgraded its rating to Sector Perform and sets its target price to $50 from $45 previously.
On June 24, 2025, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $60.
Wells Fargo Downgraded its Overweight to Equal Weight on February 24, 2025, while the target price for the stock was maintained at $36.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when Eckhardt Sue Gail sold 18,838 shares for $42.74 per share. The transaction valued at 805,140 led to the insider holds 21,380 shares of the business.
WYSZOMIERSKI JACK L sold 7,535 shares of EXEL for $324,683 on Jun 03 ’25. The Director now owns 358,882 shares after completing the transaction at $43.09 per share. On Jun 03 ’25, another insider, JACK L WYSZOMIERSKI, who serves as the Director of the company, bought 7,535 shares for $43.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 12625692672 and an Enterprise Value of 11175426048. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.49, and their Forward P/E ratio for the next fiscal year is 14.16. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.36 while its Price-to-Book (P/B) ratio in mrq is 5.83. Its current Enterprise Value per Revenue stands at 4.861 whereas that against EBITDA is 13.237.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.30, which has changed by 1.0165179 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is 7.35%, while the 200-Day Moving Average is calculated to be 25.71%.
Shares Statistics:
According to the various share statistics, EXEL traded on average about 3.32M shares per day over the past 3-months and 3414640 shares per day over the past 10 days. A total of 275.03M shares are outstanding, with a floating share count of 263.89M. Insiders hold about 3.23% of the company’s shares, while institutions hold 93.22% stake in the company. Shares short for EXEL as of 1749772800 were 20385497 with a Short Ratio of 6.14, compared to 1747267200 on 18723325. Therefore, it implies a Short% of Shares Outstanding of 20385497 and a Short% of Float of 10.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
